Earnings Releases
Walgreen Co. Reports Fourth Quarter 2009 Earnings of 44 Cents Per Diluted Share
09/29/09
|
242.0 KB |
|
| |
DEERFIELD, Ill., Sept. 29, 2009 - Walgreen Co. (NYSE, NASDAQ: WAG) today announced earnings and sales results for the fourth quarter and fiscal year 2009.
Net earnings for the quarter ended Aug. 31 were $436 million or 44 cents per diluted share, including the impact of 3 cents in costs and 7 cents in savings associated with the company's Rewiring for Growth initiative. This reflects a 1.5 percent decrease from $443 million or 45 cents per diluted share, in the same quarter a year ago. Last year's quarter included the benefit of a vacation accrual adjustment of $79 million, or 5 cents per diluted share.
Net earnings for fiscal 2009 were $2.01 billion or $2.02 per diluted share, including the impact of 16 cents in costs and 16 cents in savings associated with the Rewiring for Growth initiative. This reflects a 7.0 percent decrease from last year's $2.16 billion or $2.17 per diluted share.
Cash flow from operations increased 55 percent to $852 million for the q...
|
Walgreens Co. Reports Third Quarter 2009 Earnings Per Share of 53 Cents; Results Include 6 Cents Per Share of Restructuring Costs
06/22/09
|
140.3 KB |
|
| |
DEERFIELD, Ill., June 22, 2009 - Walgreens (NYSE, NASDAQ: WAG) today announced earnings and sales results for the third quarter of fiscal year 2009.
Net earnings for the quarter ending May 31 were $522 million or 53 cents per share (diluted), including an impact of 6 cents in costs and 6 cents in savings associated with the company's Rewiring for Growth and Customer Centric Retailing (CCR) initiatives. This reflects an 8.8 percent decrease from $572 million or 58 cents per share (diluted) in the same quarter a year ago.
Net earnings for the first nine months of fiscal 2009 were $1.57 billion or $1.58 per share (diluted), including an impact of 13 cents in costs and 9 cents in savings associated with the Rewiring for Growth and CCR initiatives. This reflects an 8.4 percent decrease from last year's $1.71 billion or $1.72 per share (diluted).
Cash flow from operations for the quarter increased 54 percent over last year's quarter to $1.5 billion, driven in large...
|
Walgreen Co. Reports Second Quarter 2009 Earnings Per Share of 65 Cents; Results Include 6 Cents Per Share of Restructuring Costs
03/23/09
|
141.8 KB |
|
| |
DEERFIELD, Ill., March 23, 2009 - Walgreens (NYSE, NASDAQ: WAG) today announced earnings and sales results for the second quarter of fiscal year 2009.
Net earnings for the quarter ended Feb. 28 decreased 6.7 percent to $640 million or 65 cents per share (diluted), from $686 million or 69 cents per share (diluted) in the same quarter a year ago. Second quarter 2009 results include a negative impact of 6 cents per share (diluted) in costs and 2 cents in savings associated with the company's Rewiring for Growth restructuring program. Last year's quarterly results benefited from one extra day because of leap year.
First half net earnings decreased 8.2 percent to $1.05 billion or $1.06 per share (diluted) versus last year's $1.14 billion or $1.15 per share (diluted). First half 2009 results include a negative impact of 7 cents per share (diluted) in costs and 3 cents in savings associated with Rewiring for Growth.
"We made solid progress in the quarter executing...
|
Walgreen Co. Reports Earnings Per Share of 41 Cents, Record Sales for First Quarter 2009
12/22/08
|
197.8 KB |
|
| |
DEERFIELD, Ill., Dec. 22, 2008 - Walgreens (NYSE, NASDAQ: WAG) today announced earnings and sales results for the first quarter of fiscal year 2009.
Net earnings for the quarter ended Nov. 30 decreased 10.4 percent to $408 million or 41 cents per share (diluted), from $456 million or 46 cents per share (diluted) in the same quarter a year ago.
Sales for the first quarter increased 6.6 percent to a record $14.9 billion, while sales in comparable stores (those open more than a year) rose 1.7 percent in the quarter.
Prescription sales, which accounted for 66 percent of sales in the quarter, climbed 6.2 percent. Prescription sales in comparable stores rose 2.6 percent in the quarter. The number of prescriptions filled in comparable stores was virtually flat, although prescriptions were up 1.5 percent when adjusted for more patients filling 90-day prescriptions versus 30-day. U.S. retail prescription volume (excluding Walgreens) decreased 0.5 percent during the sa...
|
To view PDF documents, you will need Adobe® Acrobat® Reader. Download a free copy from the Adobe website.
$0.50) 
